The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
89BIO INC | COM | 282559103 | 5,081,304 | 329,100 | SH | Call | SOLE | 329,100 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 27,728,957 | 2,421,743 | SH | SOLE | 2,421,743 | 0 | 0 | |||
AMBRX BIOPHARMA INC | SPONSORED ADS | 02290A102 | 2,410,400 | 209,600 | SH | Call | SOLE | 209,600 | 0 | 0 | ||
AMBRX BIOPHARMA INC | SPONSORED ADS | 02290A102 | 40,118,854 | 3,488,596 | SH | SOLE | 3,488,596 | 0 | 0 | |||
ARCELLX INC | COMMON STOCK | 03940C100 | 105,958,017 | 2,953,122 | SH | SOLE | 2,953,122 | 0 | 0 | |||
ARGENX SE | SPONSORED ADR | 04016X101 | 128,533,222 | 261,443 | SH | SOLE | 261,443 | 0 | 0 | |||
AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | 33,567,802 | 14,406,782 | SH | SOLE | 14,406,782 | 0 | 0 | |||
BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | 73,173,948 | 3,642,307 | SH | SOLE | 3,642,307 | 0 | 0 | |||
CARIBOU BIOSCIENCES INC | COM | 142038108 | 14,074,772 | 2,944,513 | SH | SOLE | 2,944,513 | 0 | 0 | |||
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 55,294,779 | 2,532,972 | SH | SOLE | 2,532,972 | 0 | 0 | |||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 2,199,649 | 225,605 | SH | SOLE | 225,605 | 0 | 0 | |||
COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 10,054,447 | 1,358,709 | SH | SOLE | 1,358,709 | 0 | 0 | |||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 64,795,638 | 2,178,737 | SH | SOLE | 2,178,737 | 0 | 0 | |||
DISC MEDICINE INC | COM | 254604101 | 59,771,667 | 1,272,279 | SH | SOLE | 1,272,279 | 0 | 0 | |||
IMMATICS N.V | SHS | N44445109 | 23,836,816 | 2,058,447 | SH | SOLE | 2,058,447 | 0 | 0 | |||
IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 71,865,203 | 1,384,686 | SH | SOLE | 1,384,686 | 0 | 0 | |||
INCYTE CORP | COM | 45337C102 | 52,714,952 | 912,497 | SH | SOLE | 912,497 | 0 | 0 | |||
KURA ONCOLOGY INC | COM | 50127T109 | 11,060,991 | 1,212,828 | SH | SOLE | 1,212,828 | 0 | 0 | |||
LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | 136,051,492 | 2,025,480 | SH | SOLE | 2,025,480 | 0 | 0 | |||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 72,663,133 | 1,668,116 | SH | SOLE | 1,668,116 | 0 | 0 | |||
NUVALENT INC | COM | 670703107 | 75,305,618 | 1,638,147 | SH | SOLE | 1,638,147 | 0 | 0 | |||
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 96,374,460 | 7,803,600 | SH | SOLE | 7,803,600 | 0 | 0 | |||
ROIVANT SCIENCES LTD | SHS | G76279101 | 12,635,039 | 1,081,767 | SH | SOLE | 1,081,767 | 0 | 0 | |||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 34,703,918 | 2,390,077 | SH | SOLE | 2,390,077 | 0 | 0 | |||
TG THERAPEUTICS INC | COM | 88322Q108 | 30,254,965 | 3,619,015 | SH | SOLE | 3,619,015 | 0 | 0 | |||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 69,413,013 | 307,314 | SH | SOLE | 307,314 | 0 | 0 | |||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 15,100,842 | 926,432 | SH | SOLE | 926,432 | 0 | 0 | |||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 56,477,999 | 3,681,747 | SH | SOLE | 3,681,747 | 0 | 0 | |||
VOR BIOPHARMA INC | COM | 929033108 | 13,698,310 | 6,461,467 | SH | SOLE | 6,461,467 | 0 | 0 | |||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 50,961,084 | 1,491,835 | SH | SOLE | 1,491,835 | 0 | 0 | |||
ZAI LAB LTD | ADR | 98887Q104 | 27,771,331 | 1,142,383 | SH | SOLE | 1,142,383 | 0 | 0 |